MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Yissum Technology Transfer Company of the Hebrew University of Jerusalem

Yissum Technology Transfer Company of the Hebrew University of Jerusalem
Yissum protects, promotes and markets the technologies and expertise of the University of Jerusalem

The company in detail

Profile

Yissum is the technology transfer company of the University of Jerusalem, responsible for the protection, promotion and marketing of its technologies and expertise.  

Yissum has marketed the University’s technology for over 44 years and has granted more than 250 technology licenses, the successfully commercialized products now generate almost $1 billion each year. Yissum was established in 1964 to exploit the ‘inventiveness’ of its talented staff and since then has started up 60 spin-off companies.

As the legal owner of the University’s intellectual property, Yissum has its own legal and financial departments and works closely with the researchers and staff based in the University to ensure the technologies are accessible and commercially viable by the industry’s researchers.

The technologies protected by Yissum cover a wide range of industrial and therapeutic areas, including nanotechnology, medicine and pharmaceuticals, agriculture and nutrition, water and environmental, computer science and homeland security.

Yissum’s continuous supply of promising research projects are generated from the University’s vast research base, which is funded by a research budget of $77 million and supported by a staff network of approximately 1, 400 senior faculty members.

Building on its strong commitment to the ongoing assessment, protection and commercial optimization of the University’s intellectual property, Yissum aims to

  • identify appropriate commercial partners
  • negotiate licensing agreements
  • create spin off companies
  • work closely with local and global commercial partners

Partnering strategy/interests

Collaborations, joint ventures and spin off companies are all second nature to the office and have helped to distribute and license its impressive range of technologies and products worldwide.

Yissum is interested in facilitating further collaborative research partnerships between global business partners and the university’s researchers. Partnerships can involve a single business partner or a multi party consortium.

Every partnership will be tailored to the specific requirements of the inventor, invention/technology, partner and researcher, ensuring that all partners actively contribute.

Out-licensing

Methods of Inducing Differentiation In Stem Cells, Methods of Generating Tissue Using Scaffold Matrices Derived from Micro-Organs and Stem Cells, Methods of Producing Adult Stem Cells and Method S of Continuously Generating Stem Cells By Implantation More
Whole blood quantitative diagnostic, prognostic in vitro kit for monitoring the immune status prior to and following drug treatment More
A breakthrough technique for the common multi drug resistant infections that effect patients during their stay at hospitals. This simple test provides the essential information for evidence-based treatment days before the standard testing. More
Administration of B11 peptide reduced pathologies in various inflammatory models: septic shock, colitis (-TNBS, DSS models), allergy (allergic peritonitis, allergic asthma) and changed cytokines profiles indicating immunomodulatory properties. The... More
Pressure-sensitive adhesives (PSAs) are adhesives that are capable of bonding to surfaces when light pressure is briefly applied. PSA's are used for medicinal patches, medical devices, tapes, dressings and bioelectrodes. PSAs must provide adequate... More
susceptibility test kit. Two phases / kits: Detection, and identifying the effective antibiotic against the specific type of Anthrax, including engineered Anthrax. Field test, both phases in less than 60 min. Currently no solution in the market... More
The use of the polyadenylation signal as a general and specific target for siRNA gene silencing and inhibition of viral propagation. More
HU-308, a synthetic cannabinoid has demonstrated in vivo anti-osteoporotic efficacy of agonist highly specific for CB2 that concomitantly restrains bone resorption and stimulates bone formation. HU-308 has no psychotropic or anti-annorexigenic... More
Enabling fabrics with active ingredients for antimicrobial, hygienic and other features More
The laboratory is active in the field of allergy and immunopharmacology of inflammation More
Novel use of amine-borane compounds for the treatment of medical conditions associated with microorganisms. These novel amine-borane compounds are an answer to the massive search being conducted for novel antimicrobial agents to deal with the... More
Antibodies generated in mouse lymphoma cells used to recognize human breast cancer. The antibodies in their current and modified forms can be used in the diagnosis, prognosis, and subsequent treatment of certain human breast cancers. Diagnosis of... More
The Antioxidants, Reactive Oxygen Species and Oxidative Stress Laboratory is active in the field of antioxidant-related research More
New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More
The foci of Dr. Steinberg’s laboratory are related to the study of various aspects of dental biofilms More
2-arachidonylglycerol (2-AG) is used to inhibit tumor necrosis factor alpha (TNF alpha) and as a neuroprotector of the brain in closed head injury. 2-AG can be usedalso to reduce edema caused by closed head injury, to reduce neurological deficits... More
cannabidiol (CBD) was found to b effective in reducing total area covered by artherosclerotic plaques (composed of the number and/or size of atherosclerotic plaques) in aortas and in lowering triglycerides, LDL and cholesterol levels in in-vivo... More
This novel computerized method will assist physicians in diagnosis, in prediction of clinical outcomes and possibly in formulating therapeutic approaches for treating a wide variety of cancers. The method is a general one and can successfully work... More
Natural cannabidiol is extracted from the cannabis plant. The medicaments are formulated for parenteral, oral, and transdermal administration and can also be used as a safe and effective therapy for treatment and prevention diabetes. More
Novel approach to prevention of Ca2+ passage into brain cells More
The invention provides a pharmaceutical composition comprising a stable lipid assembly comprising as a first active entity an apoptosis-affecting lipid which does not self-aggregate in a polar environment to form liposomes and a lipopolymer. The... More
A method of antitumor therapy is described in which administration of a chemotherapeutic drug, encapsulated in liposomes, is supplemented by administration of an immunostimulating cytokine. The cytokine is preferably also encapsulated in liposomes.... More
System and device for continuous, long-term prevention of biological contamination based on pulsed electrical fields (PEF) More
The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the... More
A general formulation for safe oral sustained-release administration of amoxicillin and other beta-lactam antibiotics. It is predicted that the dosing can be decreased from four times a day to only one daily dose. Keywords: controlled release,... More
Use of new bufadienolide derivatives were synthesized. These steroids have showed to affect cell growth, induce apoptosis and provoke unique changes in intracellular membrane traffic and endosomal pH. Of particular interest are the observations... More
Oral fluids can be easily and none invasively collected with low costs of collection, storage and shipment, and thus allow vast epidemiologic screening however the main drawback in oral fluids protein identification is the vast presence of Amylase... More
Proprietary algorithms were designed for identifying and designing molecules with the highest probabilities for displaying specific biological activities. The technology is based on a general algorithm for optimizing complex combinatorial problems,... More
Family of ion channel modifiers restore normal channel activity More
A method for determining presence preeclampsia in an individual. The determination can be used to detect the presence of established preeclampsia or to predict the likelihood of developing preeclampsia at a later stage of pregnancy. with... More
Combination of liposomal anti-cancer drugs and lysosome/endosome pH increasing agents for therapy More
A method for reducing activity of inflammatory immune cells by exposure to selenium. Particularly, the invention relates to a method of short-term, high dose dietary selenium supplementation for treating a subject having an inflammatory disease,... More
A simple blood test that confirms the CB receptor variant (normal or mutated) can serve as the basis for the development of novel diagnostic modalities to determine predisposition to osteoporosis and improve the diagnosis in individuals suspected of... More
Novel lipophilic prodrugs of apomorphine having high affinity to chylomicrons with intestinal lymphatic absorption potential More
Thermal Skin Burns. Civil: Treatment of Thermal Skin Burns. Keywords: formulation More
'Slow release L-DOPA analogs LDA and NALDA, for the treatment of Parkinsons disease and other related indications. LDA and NALDA are highly lipophyllic and penetrate the brain very efficiently crossing the cell membrane. This property increases the... More
Heterocyclic compounds having a relatively flexible backbone are used to create combinatorial libraries that permit screening for lead compounds and selection of drug candidates for a variety of uses in human and veterinary medicine as well as in... More
chemically modified gluococorticoids (GC), in their amphipathic weak acid form enables the effective loading in liposomes of the acidic GC. Surprisingly, the thus formed liposomal weakly acidic GC was stable, i.e. the majority of the substance... More
The present invention concerns a stable lipid assembly comprising a biologically active lipid having a hydrophobic region and a polar headgroup. These specific lipid assemblies comprise the biologically active lipid, ceramide, a lipid derivatized... More
A novel tool for designing a release profile of an active agent from a liposome in to which it is loaded. According to the invention, a method is provided for preparing a liposomal formulation for delivery of an active agent to a target, the release... More
The method for classifying medical images can be used for a variety of medical images including tissue samples, CT scans, PET scans, osteoporosis screening, thallium imaging, various cardiological tests and surgical applications. More
Effective treatment of antibiotic-resistant pathogens growing in biofilms More
An automated algorithm for prognosis of treatment success by gene expression profile (GEP) of the patient More
Simple, independent data acquisition device (DAD) at remote patient site is connected via cellular phone technology with advanced image reconstruction and hardware control multiserver unit at a central site anywhere in the world. More
A cis-acting nucleotide sequence which is capable of rendering the removal of introns from a precursor transcript encoded by a gene, which gene harbors at least one such cis-acting nucleotide sequence, occurring during the production of mRNA of a... More
Novel paltform for the nasal delivery of proteins. Promising in-vivo results in EAE models. More
Drug discovery research and development, neural tissue engineering, cell therapy, pharmacological tools, in vitro assays, neurotrophins More
The first-ever nasal platform for anti-malaria drug delivery, providing very effective drug delivery in preventing and treating acute and cerebral malaria. Keywords: formulation, nasal elka is not working on it - as per Iris. More
E. coli mazEF-mediated cell death is a quorum sensing process that involves a signal peptide molecule that termed the Extracellular Death Factor (EDF). Unlike the previously discovered quorum sensing factors of E. coli, homoserine lactones and... More
Platform drug delivery carrier technology for approved or new drugs, single drugs or combination of drugs (also including new drug combinations). More
Intra-Nasal Delivery of Medication More
Novel non-natural sphingolipid analogs which have shown better therapeutic activity, particularly anticancer activity, in comparison to cis-Pt, in various cancer cell lines such as colon, lung, and ovarian cancer. More
A novel technology of non-viral delivery of genetic material (genes, pDNA, antisense, oligonucleotides etc., termed: gene) has been developed. The gene is encapsulated in biocompatible and biodegradable polymeric nanoparticles that provide efficient... More
Novel radiolabeled compounds for radioimaging (e.g., positron emitting tomography (PET), Computed Tomography (CT), PET/CT and Single Photon Emission Tomography (SPECT)) and/or radiotherapy. These radiolabeled compounds are designed for use in a... More
A small molecule which mimics the structure of the human protein CD4 that binds to viral gp120 site. This small backbone cyclic peptide, which mimics the structure of human CD4 site that binds to the viral gp120 has been designed and synthesized... More
' Anti-HIV drugs are administered in cocktails in order to attack many targets in parallel during the viral life cycle. The major problem with the currently used anti-HIV drugs is the emergence of drug-resistant viral strains. To overcome this... More
liposomes. this project is a combimation of the following projects: 8-2006-532, 12-2006-524, 12-2006-514 for the website More
Tissue. Civil: Treatment of inflammatory related diseases: Multiple Sclerosis, Rheumatoid Arthritis etc., Treatment of Sepsis, Treatment of Thermal Burns. Keywords 'MS', 'RA'autoimmune, 'MS' More
New treatment against Gram-positive and Gram-negative bacterial infections More
A biodegradable implant capable of providing targeted radiotherapy when adjuvant therapy is needed at the surgery site or tumor bed, for the prevention of recurrence and/or development of micrometastatic disease. keywords: formulation,... More
New compounds mimicking CD4 protein, inhibiting gp120/CD4 interaction and the consequent infection of cells by HIV More
System for guided bone regeneration (GBR) by integration of osteogenesis, osteoinduction and osteoconduction processes. More
a method for an efficient entrapment of active biological material in liposomes. The method is based on the steps of drying a suspension of liposome-forming lipids and then hydrating the dry composition obtained with an aqueous solution containing a... More
Reducing Body Weight and Improving Cognitive Function More
Returned from Natspears Ltd. (Attached material in FTP Library) More
Diagnostics_ CD48 is involved in chemokine expression and eosinophil recruitment. Therefore, CD48 probably has an important role for orchestrating innate and adaptive responses in allergic lung inflammatory responses. patent only in US Babyseed... More
The laboratory is active in the field of synthesizing biologically active small molecules. The molecules can be heterocyclic and may also contain boron and phosphorus More
A novel MDR inhibiting conjugate comprising: (i) anti-MDR antibody or an antigenic binding fragment thereof for binding to an intracellular epitopes of the MDR ; (ii) a cell entering moiety; (iii) a linker. The MDR activity refers to resistance of... More
Peptide derived from the HIV-1 integrase, the INS and INRS peptides induces selective killing of HIV-1 infected cells. More
This novel protection mechanism may be of great importance in improving liposome chemical stability and protecting biological external tissues exposed to the atmosphere, such as skin and eyes, against oxidative damage from endogenous and exogenous... More
The present invention relates to novel types of peptide nucleic acids (PNAS) with improved properties. In particular, it relates to positively charged PNA units having an ethylene linker between the backbone and the nucleobase, to oligonucleotide... More
the method developed donate a new platform for peptides, ODN and peptide-ODN conjugate synthesis. It allow the formation of linear (dyad and alternate mode) branched and cyclic forms under moderate conditions and can be carried out manually or on... More
A method for the treatment of age related degeneration of the retina. Results were shown in a rat model of glaucoma. The loss of retinal function in glaucomatous rats systemically or topically treated with copaxone was significantly lower than the... More
A new composition of matter comprising microparticles with both oxidized cellulose and glucans. The composition includes pharmaceutically acceptable carrier and as an active ingredient oxidized cellulose. Preferable the oxidized cellulose should be... More
Synthetic cannabinoids, namely resorcinol derivatives, which reduce blood pressure without having psychotropic effects. The invntion includes Pharmaceutical compositions for the treatment of high blood pressure related conditions, as well as methods... More
Platforms for the design of drug delivery systems for colon cancer and other diseases More
10 new reducing molecules, prolonging their redox and protective activity. RC3 and RC4, were shown to be: Potent ROS scavengers (50 to 100 fold compared with known antioxidants), Protect cells from glucose-induced oxidative-stress. Th+D126e... More
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases More
A method for detecting pulmonary aspiration or gastroesophageal reflux comprising: orally administering to a subject a diagnostic composition comprising bio-degradable polymeric microspheres having a diameter of about 0.1-10 microns; obtaining... More
A ternary system comprising water, fatty acid or an ester thereof and alcohol or a ketone, forming spontaneously a stable, non-viscous and clear nanosized structures having cubic-like nanosized symmetry for use in solubilizing hydrophilic,... More
No in vivo data- New multifunctional steroid compound used for treating e.g. asthma, Alzheimer disease and psoriasis comprises steroid component, superoxide dismutase mimic component and optionally nitogen oxide donor component. The present... More
“Iterative Stochastic Elimination” (ISE) that can lead to extremely fast and reliable discovery of drug candidates and shorten the time for preclinical hit and lead discovery from 3-4 years to about a tenth of that time. Keywords: Alzheimer Top 30 More
The laboratory is active in the fields of synthetic organic chemistry of surfactants; physical chemistry; surface and colloid science - emulsion technology, crystallization phenomena, extraction processes; nutraceuticals; drug delivery vehicles - nanosize More
a sustained-release pharmaceutical delivery system for the administration of an antioxidant drug to a patient in need of such drug, wherein said delivery system comprises said drug in combination with a polymeric matrix, said matrix comprising a... More
Novel non-hydrolysable analogue of endogenous cannabinoids, which are found to be more potent therapeutic agents as they are more stable, for example, to hydrolytic cleavage in the gastrointestinal tract. Such compositions may be used as... More
The use of an amphipathic weak base having defined characteristics for the preparation of a pharmaceutical formulation for the treatment or prevention of neurodegenerative conditions. keywords: liposomes More
The Center for Genomic Technologies is the national research and service laboratory dedicated to detecting DNA variations and RNA expression profiling. More
Its areas of activities are process development, scale-up, and custom synthesis specifically focused to the pharmaceutical, fine chemicals and biotech fields. More
The Parasitology Laboratory is at the forefront of the battle against insects, mites and ticks, which can cause allergies, damage to the skin, and act as vectors of pathogenic micro-organisms. More
Novel heterocyclicals inhibit quorum sensing More
A platform technology that enables the coating of biological and non-biological surfaces with a matrix capable of sustained release of various active agents currently applied systemically or topically, thereby increasing effectiveness and reducing... More
A new treatment for chronic pain, Arrhythmia and degeneration and behaviour disease (such as Schizophrenia, mania-depression, Alzheimers and Parkinsons diseases). Toxin-like Proteins, first found in the Bee brain function as an endogenous modulator... More
The laboratory is active in the study and treatment of traumatic brain injury (TBI) More
Cell permeable short peptides (less than 10 a.a. in length) that are specifically designed to competitively inhibit enzyme activity of the FGF3 receptor, enabling normal bone growth. More
A method of improving renal function is disclosed. A suspension of small, unilamellar vesicles composed primarily of phospholipids similar in nature to those of egg phosphatidylcholine is administered parenterally to a subject in need of such... More
A method for the treatment of hepatic encephalopathy comprising administering to a subject in need of such treatment an effective amount of D9-tetrahydrocannabinol (THC) or Cannabidiol. keywords: hepatic, encephalopathy Originally:... More
Compounds that inhibit ubiquitin-mediated proteolysis of phosphorylated I.kappa.B by interfering, directly or indirectly, with the ability of .beta.-TrCP/E3RS to engage in protein-protein association involving hnRNP-U, are useful as drugs for... More
The use of Leptin for treating undesirable manifestations of a nutritional stress condition. The invention shows also a method for improving cognitive function by the use of Leptin keywords: neurodegenerative More
Dispersible powders and aqueous dispersions for new drug delivery possibilities More

Deals

To view this information, you must subscribe to PL Intelligence.

Press Releases

(20th Oct 2008) Yissum Technology Transfer Company of the Hebew University More
(1st Feb 2009) Technology Transfer Newsletter More
(28th Apr 2009) Yissum's Tech Transfer Newsletter Q1, 2009 More
(26th May 2009) Z-Cube, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd. Sign a Licensing Agreement for the Development of an Innovative Nanotechnology Drug Delivery System for the Treatment of Pain More
More press releases

Contact details

Mr Tamir Huberman
Director of IT & Head of BI
Management

Contact directly

Full contact list

Head office

Yissum Technology Transfer Company of the Hebrew University of Jerusalem
Hi-Tech Park, Edmond J. Safra Campus, Givat Ram
P.O. Box 39135
Jerusalem
91390
Israel

Company figures

Formed: 1964
Number of employees: 22

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Pharmalicensing Jobs
Stem Cell USA
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us